Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessCVS Health Gains 3 percent on Better Than Expected Outlook

CVS Health Gains 3 percent on Better Than Expected Outlook

Add to Favorite
Added to Favorite


CVS Health (NYSE:CVS) projected its 2024 revenue to surpass current market expectations, aiming for at least $366 billion compared to the Street’s estimate of $345.5 billion. The company is also targeting an adjusted earnings per share (EPS) of at least $8.50 for 2024, aligning with consensus forecasts. Moreover, CVS Health anticipates generating a minimum of $12.5 billion in operational cash flow. These projections were announced ahead of CVS Health’s 2023 Investor Day.
Following this announcement, CVS shares experienced a more than 3% increase intra-day today.
Additionally, CVS Health plans to introduce a novel pharmacy reimbursement model named CVS CostVantage. This model aims to transform the traditional reimbursement framework, emphasizing enhanced transparency and simplicity.
Furthermore, CVS Health reaffirmed its financial outlook for 2023. The company maintains its adjusted EPS forecast at around $8.60, with a possible variation of 10 cents, and anticipates revenues to be in the range of $351.5 to $357.3 billion. These figures are in line with the average analyst estimate, which predicts an EPS of $8.60 on revenues of approximately $353.7 billion.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Watch Samsung to launch wearable product, smart ring called Galaxy Ring, web fans are excited

Samsung (SSNLF) will soon launch its first-of-its-kind wearable product,...

Bad news for inflation: Wholesale prices rose in June

The cost of goods—including gas, electronics, and appliances—dropped by...

Benchmark Reiterates Buy Rating on JD.com, Adjusts Q2 Revenue Growth Projection

Benchmark analysts reaffirmed their Buy rating and set a...

Truist Securities Reiterates Buy Rating on Five9 Amid Activist Investor Push for Sale

Truist Securities analysts reaffirmed their Buy rating and set...